RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASMB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Assembly Biosciences
(Updated on Mar 28, 2024)

Buy or Hold candidate since Jan 12, 2024 Gain 1 541.98% PDF

The Assembly Biosciences stock price fell by -0.598% on the last day (Thursday, 28th Mar 2024) from $13.38 to $13.30. During the last trading day the stock fluctuated 3.30% from a day low at $13.02 to a day high of $13.45. The price has risen in 6 of the last 10 days and is up by 10.37% over the past 2 weeks. Volume has increased on the last day by 9 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 30 thousand shares were bought and sold for approximately $400.46 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 134X during the next 3 months and, with a 90% probability hold a price between $1,415.10 and $2,380.65 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASMB Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -2.06%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Assembly Biosciences gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The Assembly Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.93 and $11.81. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Assembly Biosciences stock

Assembly Biosciences finds support from accumulated volume at $13.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.430 between high and low, or 3.30%. For the last week, the stock has had daily average volatility of 5.31%.

Our recommended stop-loss: $12.86 (-3.31%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (ASMB) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Assembly Biosciences to open at $13.26, and during the day (based on 14 day Average True Range), to move between $12.64 and $13.96, which gives a possible trading interval of +/-$0.658 (+/-4.95%) up or down from last closing price. If Assembly Biosciences takes out the full calculated possible swing range there will be an estimated 9.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $13.33 (0.23%) than the support at $13.20 (0.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Assembly Biosciences stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Assembly Biosciences stock to perform well in the short-term.

Current score: 3.300 Buy Candidate Unchanged

Predicted Opening Price for Assembly Biosciences of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$13.26 ( 0.326%) $13.30

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASMB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.69 2.91 %
R2 13.52 1.67 %
R1 13.42 0.91 %
Current price: 13.30
Support S1 13.09 -1.56 %
S2 12.99 -2.32 %
S3 12.83 -3.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.47 1.28 %
R2 13.45 1.13 %
R1 13.33 0.226 %
Current price 13.30
Support S1 13.20 -0.752%
S2 12.35 -7.14%
S3 12.27 -7.74%

FAQ

What is the symbol for Assembly Biosciences Stock and on which exchange is it traded?
The symbol for Assembly Biosciences is ASMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Assembly Biosciences Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Assembly Biosciences stock to perform well in the short-term.

How to buy Assembly Biosciences Stock?
Assembly Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Assembly Biosciences Stock.

What's the current price of Assembly Biosciences Stock?
As of the end of day on the 2024-03-28, the price of an Assembly Biosciences (ASMB) share was $13.30.

What is the 52-week high and low for Assembly Biosciences Stock?
The 52-week high for Assembly Biosciences Stock is $13.94 and the 52-week low is $0.641.

What is the market capitalization of Assembly Biosciences Stock?
As of the 2024-03-28, the market capitalization of Assembly Biosciences is 72.921M.

When is the next earnings date for Assembly Biosciences?
The upcoming earnings date for Assembly Biosciences is May 02, 2024.
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT